Stay updated on Erythromycin for APC Stop Codon Mutations in FAP Clinical Trial
Sign up to get notified when there's something new on the Erythromycin for APC Stop Codon Mutations in FAP Clinical Trial page.

Latest updates to the Erythromycin for APC Stop Codon Mutations in FAP Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedFooter updates include a new 'Revision: v3.3.3' and the removal of 'HHS Vulnerability Disclosure' and 'Revision: v3.3.2'. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check20 days agoNo Change Detected
- Check27 days agoNo Change Detected
- Check41 days agoChange DetectedRevision history shows v3.3.2 added and v3.2.0 removed, indicating a software version update.SummaryDifference0.1%

- Check48 days agoChange DetectedA government funding status notice at the bottom of the page has been removed. The study details, contacts, and eligibility information remain unchanged.SummaryDifference0.4%

- Check63 days agoChange DetectedThe new page shows only minor visual/layout updates, and core study information remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check91 days agoChange DetectedSummary: The page adds a government-operating-status notice and a v3.2.0 release tag, while removing the v3.1.0 tag. The new notice is the significant change, signaling updated operating status and potential transaction delays.SummaryDifference4%

- Check99 days agoChange DetectedUpdated revision to v3.1.0 and added contact/identifier details; removed old revision v3.0.2.SummaryDifference0.1%

Stay in the know with updates to Erythromycin for APC Stop Codon Mutations in FAP Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Erythromycin for APC Stop Codon Mutations in FAP Clinical Trial page.